Literature DB >> 8435018

Compliance with growth hormone treatment--are they getting it?

S L Smith1, P C Hindmarsh, C G Brook.   

Abstract

A study was undertaken to investigate compliance in patients receiving growth hormone treatment. Two hundred patients completed a questionnaire designed to establish understanding about and compliance with treatment; 50% of our patients failed to comply with all aspects of their treatment. Failure to respond to treatment seems to be associated with poor compliance.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8435018      PMCID： PMC1029189          DOI： 10.1136/adc.68.1.91

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  1 in total

1.  Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.

Authors:  P J Smith; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791
  1 in total
  28 in total

1.  Compliance with growth hormone treatment--are they getting it?

Authors:  S L Smith; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

2.  Patient knowledge and compliance with growth hormone treatment.

Authors:  R Stanhope; L Moyle; M MacSwiney
Journal:  Arch Dis Child       Date:  1993-04       Impact factor: 3.791

3.  Dissolving microneedle patch for transdermal delivery of human growth hormone.

Authors:  Jeong Woo Lee; Seong-O Choi; Eric I Felner; Mark R Prausnitz
Journal:  Small       Date:  2011-01-04       Impact factor: 13.281

4.  Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.

Authors:  M L Drent; S Jakobsdottir; J A E van Wijk; W Oostdijk; J M Wit
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

5.  Growth hormone treatment without a needle using the Preci-Jet 50 transjector.

Authors:  P Bareille; M MacSwiney; A Albanese; C De Vile; R Stanhope
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

6.  COMPLIA: A 12-MONTH PROSPECTIVE, MULTICENTRE, NON-INTERVENTIONAL STUDY TO EVALUATE TREATMENT ADHERENCE AND TREATMENT SATISFACTION IN A GROWTH HORMONE DEFICIENT PAEDIATRIC POPULATION TREATED WITH NUTROPINAQ® A SOMATROPIN ANALOGUE.

Authors:  C P Dumitrescu; C Procopiuc; N Dumitriu; I Micle; M Anton; A Moisuc
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

7.  Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment.

Authors:  R J Postlethwaite; D M Eminson; J M Reynolds; A J Wood; S Hollis
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

8.  A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.

Authors:  Wayne V Moore; Huong Jil Nguyen; Gad B Kletter; Bradley S Miller; Douglas Rogers; David Ng; Jerome A Moore; Eric Humphriss; Jeffrey L Cleland; George M Bright
Journal:  J Clin Endocrinol Metab       Date:  2015-12-16       Impact factor: 5.958

9.  Non-compliance with growth hormone treatment in children is common and impairs linear growth.

Authors:  Wayne S Cutfield; José G B Derraik; Alistair J Gunn; Kyle Reid; Theresa Delany; Elizabeth Robinson; Paul L Hofman
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

10.  User assessment of Norditropin NordiFlex(®), a new prefilled growth hormone pen: a Phase IV multicenter prospective study.

Authors:  Maithé Tauber; Delphine Jaquet; Monique Jesuran-Perelroizen; Marc Petrus; Anne Marie Bertrand; Regis Coutant
Journal:  Patient Prefer Adherence       Date:  2013-05-24       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.